Join our network of experts in a discussion about the importance of diagnostics and artificial intelligence in healthcare
Artificial Intelligence (AI) is revolutionizing healthcare and diagnostics. AI is being applied in prevention and early disease detection, in customized treatments, curative therapies and for digital therapeutics. AI can enhance the workflow of radiologists by accelerating reading time and automatically prioritizing urgent cases.
How will the future of AI in healthcare look like, and which challenges will we need to overcome to get there?
- What will be possible in 2030-40 in terms of AI applications for diagnostics?
- How can machine learning be applied in pharma?
- What are ethical issues of algorithms in a patient context?
- How can we validate the integrity of the collected data?
- How do AI companies get the right patient data inputs?
These and many more questions are to be discussed by an exquisite group of experts. You are free to join the discussion at any time and asks.
|Organizer||Switzerland Global Enterprise|
Register for one session and get access to all!
This is your opportunity to listen and join discussions with about 20-30 subject matter experts and colleagues alike. With all our sessions taking place on one day, you can listen in on one session first, and then join another discussion with just one click.
09:00AM-10:00AM CET // 04:00PM-05:00PM Korean Standard Time
05:00PM-06:00PM CET // 11:00AM-12:00AM Eastern Standard Time
Prof. Andrea Danani
Bart De Witte
Bart de Witte is a leading and distinguished expert for digital transformation in healthcare in Europe, but also one of the most progressive thought leaders in his field. He focuses on developing alternative strategies for creating a more desirable future for the post-modern world, and for all of us. He is the initiator of the non-profit organization, HIPPO AI Foundation, located in Berlin. This non-profit aims to make artificial intelligence in medicine a common good, building a foundation for a sustainable and equitable society. He is an advisor to several companies and startups specializing in digital health, and lectures frequently at various business universities in Germany, Belgium, Switzerland, Austria and China.
Christopher Rudolf the founder & CEO of Volv Global SA based in Lausanne, an applied data science company, that creates cutting edge approaches to solving difficult problems in healthcare and life sciences. He is passionate about innovation, thinking aloud/allowed and entrepreneurship and applying it in the healthcare and life sciences industry to help improve the patient experience of living with disease. Christopher hasover 30 years of experience as a technology entrepreneur and independent business advisor, having worked for many Blue-Chip organisations helping solve their critical global scale data problems.
Norbert Farkas is a Swiss-Hungarian citizen. He is the Founder & Managing Partner of Centivis AG a boutique (Digital) Diagnostics Market Access and Policy Consulting firm based out of Switzerland. Prior starting his own advisory firm, he supported multiple innovative pharmaceuticals, vaccines and in-vitro diagnostics product launches from the access and policy perspectives at Novartis and Roche Global headquarters. He started his career at the European Parliament. Norbert holds a master’s degree in Economics from the Budapest University of Economics and Public Administration and an MBA from University of St. Gallen. He regularly coaches digital health start-ups, and lectures health policy students at University of Lucerne.